WHO ICTRP trial

IQUO-Ledger- Prospective non-interventional study for the characterisation of…

DRKS00004355 · German Clinical Trials Register · Not Recruiting

Key facts

Trial ID DRKS00004355
Public title IQUO-Ledger- Prospective non-interventional study for the characterisation of routine practice of Cabazitaxel and other therapyoptions for treatment of patients with metastasizing castration resistent prostate cancer (mCRPC) in established doctors´practice with emphasis on oncological urology
Scientific title IQUO-Ledger- Prospective non-interventional study for the characterisation of routine practice of Cabazitaxel and other therapyoptions for treatment of patients with metastasizing castration resistent prostate cancer (mCRPC) in established doctors´practice with emphasis on oncological urology - HOPE…
Primary sponsor Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e.V. (IQUO)
Registry German Clinical Trials Register
Recruitment status Not Recruiting
Study type observational
Countries Germany
Conditions C61;Malignant neoplasm of prostate
Interventions Group 1: Application of Cabazitaxel as single treatment regimen Group 2: Application of Cabazitaxel as adjunction
Registration date May 9, 2012
Target size 500
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations